Xiao-Lin Yu Selected Research

Xiao-Lin Yu Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 05/2014
6	Gliosis 06/2021 - 05/2014
5	Neuroinflammatory Diseases 01/2023 - 05/2014
4	Insulin Resistance 01/2021 - 01/2016
4	Parkinson Disease (Parkinson's Disease) 01/2019 - 11/2016
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 10/2015
3	Tauopathies 04/2024 - 01/2019
3	Huntington Disease (Huntington's Disease) 02/2020 - 11/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020 - 05/2014
2	Pathologic Processes 01/2019 - 11/2016
2	Inflammation (Inflammations) 01/2018 - 01/2016
2	Body Weight (Weight, Body) 01/2018 - 01/2016
2	Memory Disorders (Memory Loss) 01/2016 - 05/2014
2	Leukemia 06/2009 - 05/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Genomic Instability 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2019
1	Thrombosis (Thrombus) 02/2019
1	Myocardial Infarction 02/2019
1	Death (Near-Death Experience) 02/2019
1	Ataxia (Dyssynergia) 11/2018
1	Ophthalmoplegia (External Ophthalmoplegia) 11/2018
1	Muscle Weakness 11/2018
1	Leigh Disease (Leigh's Disease) 11/2018
1	Movement Disorders (Movement Disorder) 10/2018
1	Amyloid Plaque 01/2018
1	Hepatitis B 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Melanoma (Melanoma, Malignant) 08/2017
1	Neoplasms (Cancer) 08/2017
1	Amyloidosis 11/2016
1	Hyperglycemia 01/2016
1	Infections 10/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2008

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 06/2021 - 01/2016
5	Amyloid (Amyloid Fibrils)IBA 01/2019 - 05/2014
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 01/2016
3	SynaptophysinIBA 06/2021 - 01/2019
3	Huntingtin ProteinIBA 02/2020 - 11/2016
3	SynucleinsIBA 01/2019 - 11/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2016
2	AntibodiesIBA 01/2023 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 05/2008
2	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2019
2	Rutin (Rutoside)IBA 06/2021 - 05/2014
2	Scavenger Receptors (Scavenger Receptor)IBA 11/2020 - 01/2020
2	polyglutamineIBA 02/2020 - 10/2018
2	ResveratrolIBA 01/2019 - 12/2018
2	tau Proteins (tau Protein)IBA 01/2019 - 01/2018
2	AutoantibodiesIBA 01/2019 - 01/2016
2	VaccinesIBA 01/2018 - 01/2018
2	Islet Amyloid PolypeptideIBA 01/2018 - 10/2015
1	Serum AlbuminIBA 04/2024
1	Immunoglobulin Fab FragmentsIBA 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	NF-kappa B (NF-kB)IBA 06/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Ellagic AcidIBA 02/2020
1	Neuroprotective AgentsIBA 02/2020
1	Mitochondrial DNA (mtDNA)IBA 11/2018
1	diazonaphthalenedisulfonic acid (NDS)IBA 11/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	hydroxide ionIBA 08/2017
1	peptide SVYDFFVWLIBA 08/2017
1	Peptides (Polypeptides)IBA 08/2017
1	AntigensIBA 08/2017
1	Small Interfering RNA (siRNA)IBA 08/2017
1	Single-Chain AntibodiesIBA 11/2016
1	EpitopesIBA 11/2016
1	CholesterolIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Nonesterified Fatty Acids (NEFA)IBA 01/2016
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 05/2014
1	Malondialdehyde (Propanedial)IBA 05/2014
1	Interleukin-6 (Interleukin 6)IBA 05/2014
1	Glutathione (Reduced Glutathione)IBA 05/2014
1	OxidesIBA 05/2014
1	InterleukinsIBA 05/2014
1	PR 39IBA 10/2009
1	HomoharringtonineIBA 06/2009
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2008

Therapy/Procedure

2	Percutaneous Coronary Intervention 01/2022 - 02/2019
1	Stents 02/2019
1	Oral Administration 01/2018
1	Therapeutics 08/2017